We discuss recent advances in Gd-based T 1 -weighted MR contrast agents for the mapping of cellular pH. The pH plays a critical role in various biological processes. During the past two decades, several MR contrast agents of strategic importance for pH-mapping have been developed. Some of these agents shed light on the pH fluctuation in the tumor microenvironment. A pH-responsive self-assembled contrast agent facilitates the visualization of tumor size as small as 3 mm 3 . Optimization of various parameters is crucial for the development of pH-responsive contrast agents. In due course, the new contrast agents may provide significant insight into pH fluctuations in the human body.
INTRODUCTION

Proton (H +
is the smallest cationic species. It plays a crucial role in various biological events such as cell proliferation, apoptosis, enzymatic activity, protein degradation, and many other phenomena (1, 2) . The H + /pH concentrations are maintained within a narrow and restricted range (7.1-7.4) in the intracellular region by the membrane proton pump/proton transporter (3) . The cytoplasmic pH sensor-regulator directly controls this process (4) . Under normal physiological conditions, the protons flow from the extracellular environment to the intracellular region. However, the proton gradient in cancer cells occurs in the reverse direction to that in normal cells and away from cells to the extracellular regions. Anaerobic glycolysis in cancer generates lactic acid, which is transported to the extracellular region by carbonic anhydrase. Thus, the tumor extracellular environment is acidic (≤ 6.8). Such reverse proton gradient (Warburg effect) in cancer cells reduces the activity of cellular receptors and propagates a heterogenic tumor environment of hypoxia (5) , which prevents the entry of chemotherapeutic agents to the tumor region. On the other hand, bacterial infections or pathogenic inflammation also creates an acidic environment (6, 7) due to macrophage infiltration (8 In the last decade, the major emphasis was placed on the development of pH-responsive T 1 -weighted (W) Gd-based MR contrast agents. The Gd 3+ -based contrast agent can be readily synthesized by incorporating a pH-responsive group in the DOTA/DTPA moiety, where the T 1 relaxivity fluctuated depending on the variation in the number of water molecules in the first coordination sphere of Gd
3+
. Also, pHdependent changes in Gd-based aggregation is another strategy designed for the development of pH-dependent T 1 -W MR contrast agents.
In this review, we describe the critical features of Gdbased pH-responsive T 1 -W MR contrast agents, the approaches for development of such contrast agents, and prospective applications in an animal model.
Gd
3+ -Based T 1 MRI Contrast Agents and Relaxivity
Paramagnetic T 1 contrast agents positively influence MR images by changing the relaxation rate of water protons in the immediate vicinity of the contrast agent in the tissues. Such phenomenon was first demonstrated in the animal model using the Mn 2+ complex (20) . Since then, Gd 3+ complexes have been used extensively as MR contrast agents for whole body imaging of humans. In 1988, a Gdbased MR contrast agent was used for the first time in clinical diagnosis. Since then, it has been routinely used as an invaluable component of MRI for disease diagnosis (21) . Gd 3+ -based contrast agents positively improve the longitudinal and transverse relaxation rates of the coordinated water proton. Nonetheless, the percentage of longitudinal relaxation of water proton is primarily enhanced to provide bright images. Commercially, cyclic and acyclic poly-aminocarboxylate derivatives are used as Gd 3+ chelating agents for T 1 -W MR imaging, in which single water molecules are coordinated to Gd 3+ to generate sufficient proton relaxivity with high thermodynamic stability ( Fig. 1) . Currently available contrast agents are based on longitudinal relaxivity (r 1 ) of protons in the water molecules, which is directly coordinated with the Gd 3+ ion in the first coordination sphere. The paramagnetic relaxation theory derived by Solomon-Bloembergen-Morgan (SBM) suggests (22) (23) (24) (25) that proton relaxivity is proportional to the number of water molecule in the first coordination sphere, the fraction of bulk water in the secondary coordination sphere, and rapid water exchange rate (low water residence time to the metal ions) (Fig. 2) . On the other hand, the proton relaxivity is inversely proportional to the tumbling motion. Under high contrast movement, the longitudinal relaxivity is low. For example, the longitudinal relaxivity (r 1 ) of one of the commercially available vascular contrast agents, Vasovist (MS-325), is increased 10-fold upon binding with the human serum albumin protein (26) .
Recently, new paramagnetic contrast agents have been designed from inexpensive materials, e.g., polyaminocarboxylate, by optimizing the aforementioned parameters to obtain better relaxivity at higher magnetic fields (27) . Most importantly, the new contrast agent yields significant data based on different analytes in the living system. The optimization of various relaxivity parameters in MR contrast agents for the estimation of pH fluctuation is critically described.
Design of pH-Responsive T 1 Contrast Agents and pH Sensing
As described, the pH-dependent changes in relaxivity of the contrast agent can be obtained by optimizing the relaxivity parameter. In 1999, Zhang and coworkers (28) developed a pH-responsive contrast agent using a tetra-carboxy amide-substituted cyclen combined with a non-coordinated phosphonate functionality ([Gd(1)]). It increased the relaxivity from pH 4 to 6. By contrast, the relaxivity decreased from pH 6 to 8.5. Such unusual behavior is attributed to the extensive H-bonding between the phosphonate moiety and the bulk water, which facilitated proton exchange between coordinated water and bulk water molecules, and enhanced the waterproton exchange rate. In 2008, the same group developed a dendrimer-based pH-responsive contrast agent [(Gd (11) ] (29) . The proton exchange rate between the bulk solvent and water molecules in the inner sphere and the second hydration spheres significantly altered the dendrimer contrast agent depending on the solvent pH. Ultimately, the T 1 relaxivity is significantly affected by the pH of the bulk solution. The pH of kidney and tumor was estimated in vivo using this contrast agent by comparing ∆r 1 with the absolute r 1 value (30). The contrast agent was used in C6 glioma imaging using both high resolution pH e (extracellular pH) mapping and TMI (time to maximal intensity). The pHe value varied within the heterogenic tumor environment and the overall pH was 6.87 ± 0.01 (± SE) (Fig. 3) . To analyze the relationship between pHe and perfusion, the pH e and TMI were compared pixel to pixel, showing robust correlation between pH e and TMI throughout the tumor (R = 0.7). (Fig. 4) , which showed R 2 /R 1 changes depending on pH variation in the solution. The changes in ratiometric relaxivity at higher magnetic field were estimated at 600 MHz and 25°C. The ratiometric relaxivity ratio (R 2 /R 1 ) increased gradually from pH 7 to pH 12 (Fig. 5) . The R 2 /R 1 relaxivity ratio of Gd-1 was independent of absolute concentrations of contrast agent; instead, the molecular tumbling motion, water exchange rate, and electronic relaxation were optimized to map pH fluctuation. Figure 6 , the relaxivity (r 1 ) decreased gradually with increase in the pH. Dynamic light scattering (DLS) study was used to demonstrate the increased aggregation of both Gd@C 60 (OH) x and Gd@ C 60 [C(COOH) 2 ] 10 at lower pH at hydrodynamic diameters of 700 nm and 1200 nm, respectively, at pH 4. By contrast, the diameter was reduced to 70 nm and 50 nm, respectively, at pH 9. The reduction in the hydrodynamic radius of Gdfullerene at higher pH directly influenced the tumbling motion to minimize the relaxivity. We reported Gd-based MR contrast agents with uridine conjugation (33) . The self-assembled contrast agent Gd-2 (LGd3) showed pHdependent changes in relaxivity, probably due to the changes in aggregation and proton exchange rate (Fig. 7) of water in variable pH-buffer solution.
Further, Woods et al. (34) have developed a new Gd 3+ -based contrast agent with p-nitrophenolic pendant arm Gd-3 (NP-DO3A; 2,2',2''-(10-(2-hydroxy-5-nitrobenzyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetic acid). The study investigated the effect of pH on relaxivity at 20 MHz and 25°C. The relaxivity of the contrast agent Gd-3 was gradually reduced with increasing pH; however, the amide form of Gd-3 (NP-DO3AM; 2,2',2''-(10-(2-hydroxy-5-nitrobenzyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl) triacetamide) failed to show such pH-dependent variation (Fig. 8) . The relaxivity (r1) of Gd-3 (NP-DO3A) at pH4 was the highest (7.0 mM -1 s -1 ), which was similar to the hydration number 2 in case of Gd(DO3A) (6.9 mM , which was similar to DOTA with a hydration number 1. Such pH-dependent relaxivity changes in Gd-3 were attributed to the phenolic proton transfer, following ionization at higher pH resulting in induction of negative charge density on the metal ion complex. Most importantly, this contrast agent was stable against endogenous anionic species and Zn 2+ ion. Frullano et al. (35) have reported the development of a Gd-DOTA-based MR contrast agent with non-coordinated extended phosphonate functionality along with a PETresponsive 19 F unit. The contrast agent Gd-DOTA-4AMP-F facilitated pH estimation via T 1 -W MRI and PET. Later, the same group developed two new sulfonamide-conjugated contrast agents (Fig. 9) , which exhibited changes in relaxivity because of the increases in hydration number from 0 to 2 at lower pH. Unfortunately, such probes are not stable under biological conditions due to the instability of Gd-complex (36).
Kim and his group (37) have developed pH-responsive micelles in which PEG-p(L-LA)-DTPA-Gd was encapsulated by pH-responsive oligomer PEG-p(L-His). At physiological pH, the stable self-assembled micelle resulted in low T 1 relaxivity due to the lower population of the water molecules in the primary coordination sphere. On the other hand, the low pH in the tumor microenvironment facilitated protonation of histidine residue in PEG-p(L-His). Thus, the micelle was dissembled, which increased the water molecule population in the primary coordination sphere; subsequently, the T 1 relaxivity was increased multifold. The new strategic contrast agent allowed detection of tumors measuring 3 mm 3 with a low diameter. Such strategy prompted the development of new contrast agents that were potentially successful in clinical trials.
In conclusion, we discussed the recent development of pH-driven Gd 3+ -chelated T 1 MR contrast agents. Cyclen-based contrast agents have been designed for pH assessment. Uncoordinated phosphonate-based and dendrimer contrast agents were used in small animal models to map pH fluctuation in kidneys and tumors. Manipulation of parameters, such as aggregation-induced changes in relaxivity, as well as changes in water proton exchange rate and hydration number in the primary coordination sphere led to the development of pH-responsive contrast agents. However, the variation in pH-dependent hydration number does not have any real-world application as such contrast agents are unstable under physiological conditions. The local concentrations of Gd 3+ chelator play a significant role in contrast enhancement. Therefore, the development of Gd 3+ -based agents with the potential to estimate proton density (pH) in disease states, is a challenge. As MRI is the most preferable noninvasive tool for diagnosis, a new set of contrast agents will be developed to overcome the limitations associated with the present contrast agent. 
